Precision medicine in cancer research represents a transformative approach, customizing treatments based on individual genetic profiles, tumor characteristics, and environmental factors. By leveraging cutting-edge technologies like genomic sequencing and molecular analysis, oncologists can precisely target cancer drivers, optimizing treatment outcomes while minimizing side effects. This tailored strategy not only enhances therapeutic efficacy but also fuels the development of novel targeted therapies and immunotherapies. Moreover, the integration of artificial intelligence and big data analytics enables the identification of biomarkers for early detection and prediction of treatment response. Cancer precision medicine marks a pivotal shift in oncology, offering newfound hope and personalized solutions tailored to each patient's distinct biological landscape.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States